Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Alemu Tekewe"'
Autor:
Larance Ronsard, Ashraf S. Yousif, Julianne Peabody, Vintus Okonkwo, Pascal Devant, Alemu Tekewe Mogus, Ralston M. Barnes, Daniel Rohrer, Nils Lonberg, David Peabody, Bryce Chackerian, Daniel Lingwood
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The ligand-binding surface of the B cell receptor (BCR) is formed by encoded and non-encoded antigen complementarity determining regions (CDRs). Genetically reproducible or ‘public’ antibodies can arise when the encoded CDRs play deterministic ro
Externí odkaz:
https://doaj.org/article/c501fb4e290e4b8e90012f7b9a25ca18
Autor:
Bailey Brooks, Christina Tancredi, Yufeng Song, Alemu Tekewe Mogus, Meei-Li W. Huang, Haiying Zhu, Tuan L. Phan, Harrison Zhu, Alexandra Kadl, Judith Woodfolk, Keith R. Jerome, Steven L. Zeichner
Publikováno v:
Viruses, Vol 14, Iss 9, p 1872 (2022)
Beyond their pulmonary disease, many COVID-19 patients experience a complex constellation of characteristics, including hyperinflammatory responses, autoimmune disorders, and coagulopathies. However, the pathogenesis of these aspects of COVID-19 is o
Externí odkaz:
https://doaj.org/article/66f893d4aea54bc5a35a2c51e7fe228b
Autor:
Alemu Tekewe Mogus, Lihong Liu, Manxue Jia, Diane T. Ajayi, Kai Xu, Rui Kong, Jing Huang, Jian Yu, Peter D. Kwong, John R. Mascola, David D. Ho, Moriya Tsuji, Bryce Chackerian
Publikováno v:
Vaccines, Vol 8, Iss 4, p 765 (2020)
Broadly neutralizing antibodies (bnAbs) isolated from HIV-infected individuals delineate vulnerable sites on the HIV envelope glycoprotein that are potential vaccine targets. A linear epitope within the N-terminal region of the HIV-1 fusion peptide (
Externí odkaz:
https://doaj.org/article/7c20e2cd5e4e464ab997e749a25071d5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David S. Peabody, Alemu Tekewe Mogus, Daniel K. Rohrer, Daniel Lingwood, Larance Ronsard, Bryce Chackerian, Ralston M. Barnes, Nils Lonberg, Ashraf S. Yousif, Vintus Okonkwo, Julianne Peabody, Pascal Devant
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
The ligand-binding surface of the B cell receptor (BCR) is formed by encoded and non-encoded antigen complementarity determining regions (CDRs). Genetically reproducible or ‘public’ antibodies can arise when the encoded CDRs play deterministic ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38127103efd9c71ac1f3d7f4b2f8c9ee
https://doi.org/10.3389/fimmu.2021.730471
https://doi.org/10.3389/fimmu.2021.730471
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
John R. Mascola, Manxue Jia, Peter D. Kwong, Jing Huang, Lihong Liu, Kai Xu, Diane T. Ajayi, Rui Kong, David D. Ho, Bryce Chackerian, Alemu Tekewe Mogus, Jian Yu, Moriya Tsuji
Publikováno v:
Vaccines
Volume 8
Issue 4
Vaccines, Vol 8, Iss 765, p 765 (2020)
Volume 8
Issue 4
Vaccines, Vol 8, Iss 765, p 765 (2020)
Broadly neutralizing antibodies (bnAbs) isolated from HIV-infected individuals delineate vulnerable sites on the HIV envelope glycoprotein that are potential vaccine targets. A linear epitope within the N-terminal region of the HIV-1 fusion peptide (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea0dca2d68b29c6e294cdc6aa91c63f
Autor:
Jing Huang, Vrc Production Program, John R. Mascola, Kai Xu, David D. Ho, Lihong Liu, Peter D. Kwong, Manxue Jia, Rui Kong, Diane T. Ajayi, Moriya Tsuji, Bryce Chackerian, Jian Yu, Alemu Tekewe Mogus
Broadly neutralizing antibodies (bnAbs) isolated from HIV-infected individuals delineate vulnerable sites on the HIV envelope glycoprotein that are potential vaccine targets. A linear epitope at the N-terminal region of the HIV-1 fusion peptide (FP8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c60d7d961cb0ab5b0bcb6bd46acf7b2
https://doi.org/10.1101/2020.09.25.308957
https://doi.org/10.1101/2020.09.25.308957
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biotechnology and Bioengineering. 114:397-406
A high global burden of rotavirus disease and the unresolved challenges with the marketed rotavirus vaccines, particularly in the developing world, have ignited efforts to develop virus-like particle (VLP) vaccines for rotavirus. While rotavirus-like
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1feef8db9c1da38769f64f99e7398eca
https://doi.org/10.1002/bit.26068
https://doi.org/10.1002/bit.26068